Friday, June 26, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 793 of 1,261

  1. US 8834854

    Oral treatment compositions and related methods of manufacture

    Ranir, LLC · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted

  2. US 8835402

    Compound and method for treating myotonic dystrophy

    Sarepta Therapeutics, Inc. · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted

  3. US 8834896

    Vault compositions for immunization

    The Regents of the University of California · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted

  4. US 8835378

    Multi-domain amphipathic helical peptides and methods of their use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted

  5. CA 2903132

    CABAZITAXEL ET SON UTILISATION POUR LE TRAITEMENT DES CANCERS DE LA PROSTATE METASTATIQUES

    AVENTIS PHARMA SA [FR] · Granted Sep 12, 2014 · Expires Sep 7, 2034

    granted

  6. US 8828722

    Isolated populations of renal stem cells and methods of isolating and using same

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  7. US 8829007

    Inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  8. US 8828979

    Salicylic acid gel

    Essential Ingredients, Inc. · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  9. US 8828996

    Morpholine-spirocyclic piperidine amides as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  10. US 8828971

    Galactose-pronged carbohydrate compounds for the treatment of diabetic nephropathy and associated disorders

    GALECTIN THERAPEUTICS, INC. · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  11. US 8828936

    Therapeutic use of SCGB3A2

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  12. US 8828725

    Culture medium

    HON HAI PRECISION INDUSTRY CO., LTD. · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  13. US 8828652

    Elimination of N-glycolylneuraminic acid from animal products for human use

    The Regents of the University of California · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  14. US 8828448

    Decellularisation of tissue matrices for bladder implantation

    Tissue Regenix Limited · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  15. US 8828399

    Cytomegalovirus surface protein complex for use in vaccines and as a drug target

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  16. US 8828407

    Chimaeric protein

    The Pirbright Institute · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  17. US 8828383

    Nanocarriers with multi-photon response elements

    The Regents of the University of California · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  18. US 8828359

    Particulate materials

    Nektar Therapeutics · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  19. US 8828717

    Framework residue substituted humanized COL-1 antibodies and their use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  20. US 8828977

    Method of treating a subject suffering from degenerative disc disease using a matrix metalloprotease inhibitor

    Discogen, LLC · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  21. US 8828429

    Release-control composition

    Takeda Pharmaceutical Company Limited · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  22. US 8828380

    Method for the treatment of pulmonary disease and method of producing proteins of use therein

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  23. US 8828356

    Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  24. US 8829187

    Chiral pyrrolidine core compounds en route to inhibitors of nitric oxide synthase

    Northwestern University · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.